The renovation of institutions to support drug access: Is it enough?

Innovation in Global Health Governance: Critical Cases

Volumn , Issue , 2009, Pages 179-191

  Cohen Kohler, Jillian Clare ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900882262     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (28)

1. Alkire, Sabina and Lincoln Chen (2004). 'Global Health and Moral Values.' Lancet, vol. 364, no. 9439, pp. 1069-1074.
2. Angell, Marcia (2004). The Truth About the Drug Companies: How They Deceive Us and What to Do About It. (New York: Random House).
3. Bloche, M. Gregg (2002). 'WTO Deference to National Health Policy: Toward an Interpretive Principle.' Journal of International Economic Law, vol. 5, no. 4, pp. 825-848.
4. Chirac, Pierre and Els Torreele (2006). 'Global Framework on Essential Health R&D.' Lancet, vol. 367, no. 9522, pp. 1560-1561.
5. Commission on Intellectual Property Rights, Innovation, and Public Health (2006). Public Health: Innovation and Intellectual Property Rights. World Health Organization, Geneva. (September 2008).
6. Cullet, Philippe (2003). 'Patents and Medicines: The Relationship between TRIPS and the Human Right to Health.' International Affairs, vol. 79, no. 1, pp. 139-160.
7. Drahos, Peter (2001). 'Bilateralism in Intellectual Property.' Paper prepared for Cut the Cost of Medicines Campaign. Oxfam GB, London. (September 2008).
8. Fisher, Richard W. (1999). 'Technological Progress and American Rights: Trade Policy and Intellectual Property Protection.' Testimony before the Subcommittee on International Economic Policy and Trade House Committee on International Relations, 13 October. Washington DC.
9. Médecins Sans Frontières (2001). Fatal Imbalance: The Crisis in Research Development for Drugs for Neglected Diseases. Geneva. (September 2008).
10. Médecins Sans Frontières (2003). Doha Derailed: A Progress Report on TRIPS and Access to Medicines. 27 August. Geneva. (September 2008).
11. Oxfam International (2007). 'Investing for Life: Meeting Poor People's Needs for Access to Medicines Through Responsible Business Practices.' Briefing Paper 109. Oxfam International. (September 2008).
12. Redwood, Heinz (1995). Brazil: The Future Impact of Pharmaceutical Patents. (Suffolk: Oldwicks Press).
13. Rodrik, Dani (1997). Has Globalization Gone Too Far? (Washington DC: Institute for International Economics).
14. Saul, John Ralston (2005). The Collapse of Globalism and the Reinvention of the World. (Toronto: Viking Canada).
15. Scherer, Frederick M. (2000). 'The Pharmaceutical Industry.' In A.J. Culyer and J.P. Newhouse, eds., Handbook of Health Economics (New York: Elsevier Science).
16. Shalden, Ken (2007). 'The Political Economy of AIDS Treatment.' International Studies Quarterly, vol. 51, no. 3, pp. 559-581.
17. Stiglitz, Joseph (2006). Making Globalization Work. (New York: W.W. Norton).
18. Trouiller, Patrice, Piero Olliaro, Els Torreele, et al. (2002). 'Neglected Diseases and Pharmaceuticals: Between Deficient Market and Public Health Failure.' Lancet, vol. 359, no. 9324, pp. 2188-2194.
19. United Nations (1948). 'Universal Declaration of Human Rights.' (September 2008).
20. United Nations (1969). 'Vienna Convention on the Law of Treaties.' 23 May. United Nations Treaty Series, vol. 1155, p. 331. (September 2008).
21. United Nations Commission on Human Rights (2001). The Impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights on Human Rights - Report of the High Commissioner. U.N. Doc. E/CN.4/Sub.2/2001/13. United Nations Commission on Human Rights, Geneva.
22. United Nations Economic and Social Council. Commission on Human Rights (2001). Economic, Social, and Cultural Rights: The Impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights on Human Rights. E/CN.4/Sub.2/2001/13, 27 June. (September 2008).
23. United Nations Economic and Social Council. Committee on Economic, Social, and Cultural Rights (2000). The Right to the Highest Attainable Standard of Health. General Comment No. 14. E/C.12/2000/4, 11 August. (September 2008).
24. United Nations Office of the High Commission for Human Rights (1966). 'International Covenant on Economic, Social, and Cultural Rights.' (September 2008).
25. World Trade Organization (1994). 'Trade-Related Aspects of Intellectual Property Rights.' Annex IC of the Marrakesh Agreement Establishing the World Trade Organization. 15 April. Geneva. (September 2008).
26. World Trade Organization (2001). 'Declaration on the TRIPS Agreement and Public Health.' WT/MIN(01)/DEC/2. 14 November. (September 2008).
27. World Trade Organization (2003). 'Implementation of Paragraph 6 of the Doha Declaration of the TRIPS Agreement and Public Health.' Decision of the General Council of 30 August. (September 2008).
28. World Trade Organization (undated). 'A Summary of the Final Act of the Uruguay Round.' Geneva. (September 2008).